SIK1 and cancer: The specific mechanism is that EMT can promote the transformation of cancer cells into cancer stem cells (CSCs) and acquire drug resistance 22, 25, and we found that SIK1 can inhibit oxaliplatin resistance in oxaliplatin drug experiments and in vivo experiments.